Proteomics promises to rewrite medicine, but the analysis software has been trapped in the 2000s. Mass Dynamics took the pipeline a leading proteomics team used internally and turned it into a product any lab could run.
The four co-founders – Paula Burton (CEO), Aaron Triantafyllidis (Tech Product Lead), A/Prof Andrew Webb (Chief Scientist) and Dr Giuseppe Infusini (Proteomics Informatics Lead) – had published into top journals before they pitched us. We backed a deep-tech team that had earned the right to sell to the buyer.
Rampersand joined Mass Dynamics' seed for its cloud proteomics / mass-spec analytics platform.
Andrew partners with the team on commercial traction with global pharma and research-institution customers.